Focus: function_assignment · hypothesis slug caveola-mechanosignaling-antigen-identity
Gene: human SMPD2 / nSMase1 (UniProt O60906) · Source: genes/human/SMPD2/SMPD2-ai-review.yaml
Verdict: Over-annotated (refuted for SMPD2 specifically) for the caveola + mechanical-stimulus pair; core SMase/ceramide function retained.
The caveola (GO:0005901, CC) and response-to-mechanical-stimulus (GO:0009612, BP) annotations on human SMPD2 were propagated by PANTHER phylogenetic inference (IBA/IBD) from an experimental root on rat Smpd2 (Q9ET64, RGD:619753), which in turn rests on Czarny et al. 2003 (PMID 12473648). That paper detected a caveolar, flow/pressure-activated neutral sphingomyelinase immunologically, using antiserum raised against a purified bovine neutral SMase (Bernardo et al. 2000, PMID 10713073). The molecular identity of that bovine antigen was explicitly not any then-known SMase ("no apparent homologies … to any known protein") and was subsequently cloned as nSMase3 / SMPD4 (Krut et al. 2006, PMID 16517606: the defining peptide "allowed us to identify … nSMase3, that shows only a little homology to nSMase1 and -2").
Therefore the caveolar/mechanosensitive activity most plausibly belongs to SMPD4 (nSMase3) or an unresolved cross-reactive antigen — not SMPD2/nSMase1. No target-specific (RNAi, knockout, tagged-protein, or MS-identified) evidence places SMPD2 itself in caveolae or as a mechanosensor was found. The annotation chain is a textbook paralog/antigen carry-over.
Most important caveats: (1) I could not read the full text of PMID 12473648 to independently confirm the seed's claim that its Methods used the Bernardo antiserum and its Discussion links the enzyme to that purified protein — this rests on the seed and on the abstract-level chain, which is nonetheless internally consistent and corroborated by Krut 2006. (2) "Over-annotated" means mis-attributed to this gene, not that caveolar nSMase mechanotransduction is unreal — it is real, but the gene identity is the issue. (3) The seed's separate instruction stands: do not overturn SMPD2's independent core ceramide-generating function (PMID 25168245), which is molecularly target-specific and out of scope here.
| Citation (PMID) | Evidence type | Stance | Claim tested | Key finding | Context | Confidence / limitations |
|---|---|---|---|---|---|---|
| 12473648 (Czarny 2003) | Direct assay + localization | Qualifies (source of claim) | Is there a caveolar, mechanoactivated neutral SMase? | Flow/pressure transiently activate a caveola-enriched neutral (not acid) SMase → ceramide → ERK1/2; enzyme detected immunologically, gene identity not molecularly established | Rat lung endothelium in situ; cell-free luminal membranes | Robust for the phenomenon; does NOT identify the gene as Smpd2 |
| 15142848 (Czarny & Schnitzer 2004) | Direct assay (pharmacology) | Qualifies | Follow-up mechanotransduction pharmacology | Scyphostatin blocks, C2/C6-ceramide mimics mechanosignaling | Rat lung, bovine aorta EC, cell-free | Scyphostatin inhibits all Mg²⁺ nSMases (nSMase2/3/bovine) — not isoform-specific; cannot assign to SMPD2 |
| 10713073 (Bernardo 2000) | Direct assay (protein purification) | Refutes SMPD2 identity | What is the purified bovine nSMase antigen? | p46/p97 species; tryptic peptides "showed no apparent homologies … to any known protein"; peptide antibodies used downstream | Bovine brain | The antigen was neither nSMase1(SMPD2) nor nSMase2(SMPD3), both already cloned by 2000 |
| 16517606 (Krut 2006) | Structural/evolutionary + cloning | Refutes SMPD2 identity (competing = SMPD4) | Which gene does the bovine peptide correspond to? | Peptide from the purified bovine nSMase identified nSMase3 (SMPD4), "only a little homology to nSMase1 and -2"; ER/Golgi, C-tail-anchored, TNF-responsive | Human cDNA; yeast expression | Directly reassigns the reagent lineage to SMPD4, a distinct paralog |
| 25168245 (Yabu 2015) | Mutant/RNAi + phosphosite | Supports (independent core, out of scope) | Does SMPD2 itself generate ceramide? | JNK phosphorylates nSMase1/SMPD2 at Ser-270; stress/anti-Fas activate it; SMPD2 RNAi lowers ceramide | Zebrafish ZE + human Jurkat T | Target-specific; establishes core function, unrelated to caveola/mechano |
| Computational (this run) | Computational | Supports refutation | Are nSMase1/2/3 distinct enough that a peptide couldn't be confused? | Global-alignment pairwise identity ~22% (aligned) among SMPD2/SMPD3/SMPD4 | UniProt O60906/Q9NY59/Q9NXE4 | Crude NW scoring; directionally confirms high divergence / "little homology" |
| Gap | What was checked | Why it matters | What would resolve it |
|---|---|---|---|
| Did PMID 12473648 Methods/Discussion actually use the Bernardo antiserum and tie the caveolar enzyme to that purified protein? | Abstracts of 12473648/15142848 (no antibody named in abstract); seed asserts full-text usage | Confirms the reagent→antigen link that drives the whole judgment | Read full text of PMID 12473648 (author-deposited copy) and confirm antibody source and Western identity |
| Is the rat Smpd2 caveola IDA / mechanical IMP in RGD/QuickGO literally sourced to PMID 12473648? | Seed states QuickGO donor Q9ET64 caveola IDA + mechanical IMP (PMID 12473648) | Determines whether fixing the source annotation corrects human IBA | Inspect QuickGO/RGD annotation provenance for Q9ET64 |
| Is there any SMPD2-specific caveolar/mechanosensitive evidence (post-2006)? | PubMed searches returned none tying SMPD2 to caveola/mechanotransduction | Absence would firm up the removal lead | Targeted search + review of SMPD2 KO/tagged-localization studies |
| Exact SMPD4/nSMase3 caveolar/mechano evidence | Krut 2006 shows ER/Golgi, TNF-responsive; caveola not directly shown for SMPD4 | Decides whether the terms should move to SMPD4 vs. be dropped entirely | Isoform-specific localization/mechano assays for SMPD4 |
artifacts/evidence_matrix.csv, artifacts/go_decision_table.csv (computed provenance tables).Secondary sourcing of Bernardo et al. 2000 (PMID 10713073) clarifies that its peptide-specific polyclonal antibody was raised against a p97-derived peptide and stained a 97-kDa protein in bovine aortic endothelial cell lysates; the 46-kDa species is a breakdown product, and the antigen is a single protein. This is decisive for two reasons: (1) the p97 species is precisely the sequence that Krut et al. 2006 (PMID 16517606) used to clone nSMase3/SMPD4; and (2) the antibody was validated in bovine aortic endothelial cells, the same endothelial system used in the Czarny/Schnitzer mechanotransduction work. Thus, to the extent the caveolar mechano-nSMase was identified immunologically with this reagent lineage, it points to SMPD4/nSMase3, not SMPD2. The only residual gap is direct confirmation, from the inaccessible PMID 12473648 full text, that this exact antiserum (vs. a generic activity assay) was the identifying reagent in that paper.
Literature retrieved via PubMed (abstracts quoted verbatim). Pairwise identity of human SMPD2/SMPD3/SMPD4 (UniProt O60906/Q9NY59/Q9NXE4) computed in-run by a simple Needleman–Wunsch global alignment; the crude match-only scoring inflates the "% over shorter" figure, so only the aligned-identity (~22%) is interpreted, and solely to corroborate the published "little homology" statement. Full text of PMID 12473648 was not machine-readable in this run; the reagent→antigen link is inferred from the abstract-level chain plus the seed, and is flagged as a knowledge gap.